GREY:ATBPF - Post by User
Post by
drippingsnoton Sep 15, 2020 8:30am
353 Views
Post# 31558728
Oppenheimer Summit - Sept 22
Oppenheimer Summit - Sept 22 Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, today announced that Dan Legault, Antibe’s Chief Executive Officer, will present a corporate overview at the upcoming virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 22, 2020 at 9:10 am (Eastern Time).
A live webcast of the presentation will be available on the Company’s website at www.antibethera.com/events. Following the presentation, a replay of the webcast will be available on the website for 90 days.